Philip K. E. Granith

Philip K. E. Granith

Auto-generated profile, based on publicly available information

Philip K. E. Granith

Faculty of Science and Engineering, Pharmaceutical Science Laboratory (PSL–Pharmacy) and Structural Bioinformatics Laboratory (SBL–Biochemistry), Åbo Akademi University , Turku FI-20500

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
FWFranka G. Westermann
Franka G. Westermann
AOAdam C. Oken
Adam C. Oken
PGPhilip K. E. Granith
Philip K. E. Granith
Parthiban MarimuthuParthiban Marimuthu
Parthiban Marimuthu
CMChrista Müller
Christa Müller
SMSteven E. Mansoor
Steven E. Mansoor
The P2X2 receptor (P2X2R) is a slowly desensitizing adenosine triphosphate (ATP)-gated ion channel that is highly expressed in the cochlea. When mutated, the P2X2R exacerbates age- and noise-related hearing loss, but selective modulators of the receptor are lacking, and the molecular basis of activation and desensitization remains poorly understood. Here, we determine high-resolution cryoelectron microscopy structures of the full-length wild-type human P2X2R in an apo closed state and two distinct ATP-bound desensitized states. In the apo closed state structure, we observe features unique to the P2X2R and locate disease mutations within or near the transmembrane domain. In addition, our ATP-bound structures show how free anionic ATP forms subtype-specific interactions with the orthosteric binding site. We identify and characterize two different ATP-bound desensitized state structures, one similar to published models for other P2XR subtypes, and a second alternate conformation not previously observed. A loop adjacent to the orthosteric binding site between these two ATP-bound desensitized state structures undergoes significant conformational changes. These movements are supported by multireplicate, microsecond-scale molecular dynamics simulation studies and suggest a path by which ATP could enter or leave the orthosteric pocket. Together, our results provide structural insights into the P2X2R, facilitating structure-based drug development for this therapeutically important target.

3 August 2026 in Endocrinology
Verified
Journal Article
Open access
CHCharles F Heyder
Charles F Heyder
CMCasey Murray
Casey Murray
PGPhilip Granith
Philip Granith
MMMuhriddin Mahkamov
Muhriddin Mahkamov
EBEmma Bourget
Emma Bourget
TBTimothy S Breton
Timothy S Breton
Superconserved receptors expressed in brain (SREB) are a family of orphan G protein–coupled receptors with 3 members in most vertebrates (GPR27 or SREB1, GPR85 or SREB2, and GPR173 or SREB3). They are associated with diverse physiological processes, ranging from glucose homeostasis to ovarian development. Despite a lack of confirmed ligands, our understanding of these receptors has increased based on interactions with putative SREB3 ligands such as phoenixin (PNX) and the development of synthetic SREB1 agonists (A8535 and PT-91). However, to date no studies have used these agonists in any complex vertebrate system. The objective of this study was to compare the in vitro transcriptomic responses to PNX-20, A8535, and PT-91 in the ovaries of 3 fishes with different SREB systems: (1) zebrafish (Danio rerio) that exhibit similar receptors to mammals, (2) mummichog (Fundulus heteroclitus) that lost a receptor but gained a fish-specific member, and (3) pufferfish (Dichotomyctere nigroviridis) that exhibit all 4 receptors. Agonist interactions with fish SREB1s were confirmed using in silico characterizations. Zebrafish exhibited the strongest transcriptome response, including agonist-induced changes in oxidative phosphorylation and cell adhesion pathways. Mummichog exhibited a less robust response, possibly related to receptor evolutionary divergence, while pufferfish exhibited an intermediate transcriptome response. Short-term agonist exposure did not alter ovarian steroid levels ([17]estradiol, 17-hydroxyprogesterone, cortisol, testosterone, or 11-ketotestosterone). Collectively, the data reveal previously unrecognized developmental, metabolic, neural, and vascular gene networks associated with SREB activation and suggest both receptor-specific signaling and functional overlap within this family.